The promise and problem with exosomes in beauty

Published: 22-Sep-2025

While demand for exosome-based ingredients is on the rise, regulations are complex and unclear. CE.way’s Laura Silva explains what brands and formulators need to know

You need to be a subscriber to read this article.
Click here to find out more.

At the crossroads of biotechnology and skin care innovation, exosomes are being hailed as the next significant advancement in regenerative cosmetics.

These nano-sized extracellular vesicles, naturally secreted by living cells, play an essential role in intercellular communication and tissue repair.

Their potential to support collagen synthesis, modulate inflammation, and enhance skin barrier function is driving significant interest from formulators and beauty brands.

However, as commercial enthusiasm accelerates, critical gaps remain in clinical validation, regulatory clarity, and manufacturing standardisation.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like